Recruiting
Phase 2

Honey Wound Treatment

Sponsor:

R. Stephen Rankin, M.D.

Code:

NCT01748318

Conditions

Community-acquired Methicillin-resistant Staphylococcus Aureus Infection

Eligibility Criteria

Sex: All

Age: 16 - 70+

Healthy Volunteers: Accepted

Interventions

New Mexico Honey

Bactrim DS

Study Details

Brief summary:

In a time of emerging bacteria that are resistant to antibiotics, honey offers an alternative that has potential to reduce the heavy reliance on pharmaceutical antibiotics. We will be evaluating the effectiveness of a locally produced New Mexico Honey against the standard of care Bactrim antibiotic on Community Acquired MRSA.

Conditions

Community-acquired Methicillin-resistant Staphylococcus Aureus Infection

Study ID

NCT01748318

Start date

Mar, 2013

Status verified date

May, 2016

Completion date

Jul, 2018

Anticipated

Primary completion date

May, 2018

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 16 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Patients 16 years of age or older
  • Abscess less than or equal to 6 cm in diameter on the extremity or trunk requiring incision and drainage
  • Patient willing to try honey prepared dressing
  • Patient able to return to office each day for 7 days for evaluation

Exclusion Criteria:

  • Under the age of 16
  • Abscess of face, scalp or genitals
  • Diagnosed as a diabetic
  • Allergic to bee pollen, honey or sulfa antibiotics
  • Diagnosed with peripheral vascular disease
  • Patient acknowledgement of current drug or alcohol abuse

Study Design

Enrollment

60 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: NM Regional Honey

15 ml of NM Honey applied directly to wound

active comparator: Bactrim DS

Standard of Care Oral Antibiotic

Interventions

New Mexico Honey

Apply 15 ml of NM Honey to CA-MRSA Abscess compare to standard antibiotic treatment

Bactrim DS

Bactrim DS

Primary outcome measure

  • Size of lesion at day 7 [ Time Frame: 7 days ]

Central Contacts and Locations

Central contacts

R Stephen Rankin, MD

505 324 1000rstephen_rankin@msn.com

Joseph Pope, MD

505 324 1000jpope10@msn.com

Locations

Pinon Family Practice

Recruiting

Farmington, New Mexico, United States, 87401

Contacts

R Stephen Rankin, MD

505-324-1000

Principal Investigator:

R Stephen Rankin, MD

More Information

Sponsor

R. Stephen Rankin, M.D.

Last update posted

May 10, 2016

Last verified

May, 2016

Keywords

  • Community acquired MRSA
  • New Mexico Honey

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by R. Stephen Rankin, M.D. on 2016-05-10.